Early View

The Link Between Reproductive Life Plan Assessment And Provision of Preconception Care At Publicly Funded Health Centers

CONTEXT

Federal and clinical guidelines recommend integrating reproductive life plan assessments into routine family planning encounters to increase provision of preconception care. Yet, the prevalence of clinical protocols and of relevant practices at publicly funded health centers is unknown.

METHODS

Administrators and providers at a nationally representative sample of publicly funded health centers that provide family planning services were surveyed in 2013–2014; data from 1,039 linked pairs were used to explore the reported prevalence of reproductive life plan protocols, frequent assessment of patients’ reproductive life plan and frequent provision of preconception care. Chi-square tests and multivariable general linear models were used to examine differences in reports of protocols and related practices.

RESULTS

Overall, 58% of centers reported having reproductive life plan assessment protocols, 87% reported frequently assessing reproductive life plans and 55% reported frequently providing preconception care. The proportions reporting protocols were lower in community health centers than in other center types (32% vs. 52–91%), in primary care centers than in those with another focus (33% vs. 77–80%) and in centers not receiving Title X funding than in those with such support (36% vs. 77%). Reported existence of a written protocol was positively associated with reported frequent assessment (prevalence ratio, 1.1), and the latter was positively associated with reported frequent preconception care (1.4).

CONCLUSION

Further research is needed on associations between written protocols and clinical practice, and to elucidate the preconception care services that may be associated with reproductive life plan assessment.

Authors' Affiliations

Cheryl L. Robbins is epidemiologist, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion; and Marion W. Carter is health scientist, Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention—both at the Centers for Disease Control and Prevention, Atlanta. Loretta Gavin is senior health scientist, and Susan B. Moskosky is acting director, Office of Population Affairs, U.S. Department of Health and Human Services, Rockville, MD.

Disclaimer
The views expressed in this publication do not necessarily reflect those of the Guttmacher Institute.

Perspectives on Sexual and Reproductive Health

Support Our Work

Your support enables the Guttmacher Institute to advance sexual and reproductive health and rights in the United States and worldwide through our interrelated program of research, public education and policy analysis.